A New Perspective of COVID-19 Infection: An Epigenetics Point of View

Abstract

Coronavirus disease 2019 (COVID-2019) started in Wuhan, China, in December 2019. Angiotensin-converting enzyme 2 (ACE2) receptor was one of the most important genes related to the entrance of the virus to the host. Until now, several variations have been identified in ACE2 and related transmembrane protease serine 2. Epigenetic modifications not only play an important role during the maintenance of genome and cellular homoeostasis but also for the etiopathophysiology of the virus infection. Studies showed methylation of ACE2 was changed to depend on host and age of the host during the viral infection.
In this study, we provided an epigenetics point of view to the coronavirus infection. We highlight the importance of epigenetic modifications during viral replication and infection and their interaction with COVID-19 susceptibility and host viral response.

Keywords

COVID-19 / epigenetics / methylation

References

[1] Blanco-Melo D, Nilsson-Payant BE, Liu WC.et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell2020; 181 (05): 1036-1045.e9

[2] Chlamydas S, Papavassiliou AG, Piperi C.Epigenetic mechanisms regulating COVID-19 infection. Epigenetics 2021; 16(03): 263-270

[3] Ragia G, Manolopoulos VG.Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry. Pharmacogenomics 2020; 21(18): 1311-1329

[4] Pinto BGG, Oliveira AER, Singh Y.et al.ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. J Infect Dis 2020; 222(04): 556-563

[5] Sawalha AH, Zhao M, Coit P, Lu Q.Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol 2020; 215: 108410

[6] Wan Y, Shang J, Graham R, Baric RS, Li F.Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94(07): e00127-e20

[7] Papa G, Mallery DL, Albecka A.et al.Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog 2021; 17(01): e1009246

[8] Galupa R, Heard E.X-chromosome inactivation: a crossroads between chromosome architecture and gene regulation. Annu Rev Genet 2018; 52: 535-566

[9] Tukiainen T, Villani AC, Yen A.et al; GTEx Consortium, Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group, Statistical Methods groups—Analysis Working Group, Enhancing GTEx (eGTEx) groups, NIH Common Fund, NIH/NCI, NIH/NHGRI, NIH/NIMH, NIH/NIDA, Biospecimen Collection Source Site—NDRI, Biospecimen Collection Source Site—RPCI, Biospecimen Core Resource—VARI, Brain Bank Repository—University of Miami Brain Endowment Bank, Leidos Biomedical—Project Management, ELSI Study, Genome Browser Data Integration &Visualization—EBI, Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz. Landscape of X chromosome inactivation across human tissues. Nature 2017; 550(7675): 244-248

[10] Corley MJ, Ndhlovu LC.2020; DNA methylation analysis of the COVID-19 host cell receptor, angiotensin i converting enzyme 2 gene (ACE2) in the respiratory system reveal age and gender differences. Preprints 2020030295

[11] Corley MJ, Pang APS, Dody K.et al.Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol 2021; 110(01): 21-26

[12] Lee JS, Park S, Jeong HW.et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol2020; 5 (49): eabd1554

[13] Wilk AJ, Rustagi A, Zhao NQ.et al.A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med 2020; 26(07): 1070-1076

RIGHTS & PERMISSIONS

2022 Global Medical Genetics